The Effect of Naltrexone as a Carboplatin Chemotherapy-Associated Drug on the Immune Response, Quality of Life and Survival of Dogs With Mammary Carcinoma

PLoS ONE - United States
doi 10.1371/journal.pone.0204830
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

The Effect of Chemotherapy on Quality of Life in Patients With Lung Carcinoma

Gulhane Medical Journal
Medicine
2012English

Advanced Papillary Serous Carcinoma of the Uterine Cervix: A Case With a Remarkable Response to Paclitaxel and Carboplatin Combination Chemotherapy

Rare Tumors
OncologyHistology
2012English

Nab-Paclitaxel/Carboplatin Induction in Squamous NSCLC: Longitudinal Quality of Life While on Chemotherapy

Lung Cancer: Targets and Therapy
Oncology
2017English

Effect of the Age-Related Immune Depression Induced by MTV on the in Vivo Growth of a Mammary Carcinoma

British Journal of Cancer
Cancer ResearchOncology
1981English

Neoantigen Quality Predicts Immune Response, Survival

Cancer Discovery
Oncology
2017English

The Effect of Adjuvant Chemotherapy on Survival in Patients With Residual Nasopharyngeal Carcinoma After Undergoing Concurrent Chemoradiotherapy

PLoS ONE
Multidisciplinary
2015English

Effect of Extended-Release Naltrexone (XR-NTX) on Quality of Life in Alcohol-Dependent Patients

Alcoholism: Clinical and Experimental Research
MedicinePsychiatryMental HealthToxicology
2009English

The Effect of Intravenous Vitamin C on Cancer- And Chemotherapy-Related Fatigue and Quality of Life

Frontiers in Oncology
Cancer ResearchOncology
2014English

Chemotherapy of a Case of Thymic Carcinoma Responding Completely to Carboplatin and Docetaxel.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy